Vir Biotechnology (VIR) Tax Provisions (2018 - 2026)
Vir Biotechnology (VIR) reported Tax Provisions of $170000.0 for Q1 2026, up 962.5% on a YoY basis from $16000.0 in Q1 2025, and up 224.09% sequentially from -$137000.0 in Q4 2025.
Vir Biotechnology (VIR) Tax Provisions (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Tax Provisions data on file, last reported at $170000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 962.5% year-over-year to $170000.0; the trailing twelve-month figure through Mar 2026 stood at $371000.0 (up 126.41% YoY), and the FY2025 full-year result was $217000.0, up 118.95% from the prior year.
- Tax Provisions grew to $170000.0 in Q1 2026, from -$137000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $403.3 million in Q1 2022 to a low of -$157.2 million in Q2 2022.
- A 5-year average of $13.2 million and a median of -$86000.0 in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 205658.16% in 2022, while the deepest fall reached 296756.6% in 2022.
- Tracing VIR's Tax Provisions over 5 years: stood at -$50.0 million in 2022, then soared by 90.44% to -$4.8 million in 2023, then surged by 98.2% to -$86000.0 in 2024, then slumped by 59.3% to -$137000.0 in 2025, then surged by 224.09% to $170000.0 in 2026.
- Business Quant data shows VIR's Tax Provisions at $170000.0 in Q1 2026, -$137000.0 in Q4 2025, and $168000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | 170,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | -1.51 Mn |
| Mar 31, 2024 | 276,000.00 |
| Dec 31, 2023 | -4.78 Mn |
| Sep 30, 2023 | -3.21 Mn |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -2.23 Mn |
| Dec 31, 2022 | -50.04 Mn |
| Sep 30, 2022 | 42.42 Mn |
| Jun 30, 2022 | -157.23 Mn |
| Mar 31, 2022 | 403.29 Mn |
| Dec 31, 2021 | 20.64 Mn |
| Sep 30, 2021 | 334,000.00 |
| Jun 30, 2021 | 53,000.00 |